Peptide math guide
Peptide vial concentration vs dose: keep them apart
Use the symbolic worksheet to keep label fields and unit-conversion steps separate without choosing an amount to administer.
TL;DR
Follow the worksheet in order: record the label units, define the final-volume input, show each conversion, and stop before any administration decision.
Key takeaways
- FDA's drug-listing guide treats an injectable solid intended for reconstitution as an amount per vial and an injectable liquid as a total amount per total volume.[1]
- Concentration requires two inputs: the total amount represented in the liquid and the final liquid volume. The unit is amount per volume.[1]
- The National Cancer Institute defines a dose as the amount of medicine taken at one time. Dose remains separate from the concentration equation.[6]
- FDA says compounded drugs receive no premarket review for safety, effectiveness, or quality. Correct arithmetic cannot supply that missing review.[2]
- FDA's dietary supplement manufacturing guide requires methods, limits, and actual results on a relied-on supplier component COA. That rule belongs to the guide's supplier-component context.[3]
Four quantities need separate names
| Quantity | Meaning | Typical unit shape | Boundary |
|---|---|---|---|
| QuantityTotal vial amount | MeaningThe total active-ingredient amount represented for the vial.[1] | Typical unit shapeAmount per vial | BoundaryIt does not state concentration before final liquid volume is known. |
| QuantityFinal liquid volume | MeaningThe total liquid volume used as the denominator in the concentration. | Typical unit shapeVolume | BoundaryConcentration cannot be calculated until the final volume is stated. |
| QuantityConcentration | MeaningTotal amount divided by final liquid volume. | Typical unit shapeAmount per volume | BoundaryIt describes the liquid and does not select an administration amount. |
| QuantityDose | MeaningThe amount of medicine taken at one time.[6] | Typical unit shapeAmount | BoundaryDose is not an output of the concentration equation. |
The concentration equation uses symbols first
Let A represent the total amount in the finished liquid and V represent the final liquid volume. Concentration C equals A divided by V. The written unit should preserve that relationship as amount per volume.
A Supplement Facts panel uses another frame: ingredient quantity per labeled serving. That value belongs to the serving shown on the dietary supplement label and should not be imported into vial math.[4]
The math stops before dose selection
An equation can convert known quantities. It cannot decide whether a product is appropriate, select an administration amount, set a schedule, or determine a route.
The equation does not test its inputs. In FDA's dietary supplement manufacturing context, a relied-on supplier COA carries methods, limits, and actual results. FDA approval remains a separate agency record.[3][5]
Every conversion depends on its inputs
- FDA approval status comes from the current agency record.[5]
- In FDA's dietary supplement manufacturing context, a relied-on supplier component COA carries methods, limits, and actual results. Material traceability sits in separate manufacturing records.[3]
- The final liquid volume must be represented as a volume, because it is the concentration denominator.[1]
- Dose is the amount taken at one time, not an input to the concentration equation.[6]
The Peptide COA vs Supplement Facts guide shows how to keep a declared amount separate from a batch test result. It does not establish final liquid volume.
Related peptide label guides
Peptide label guide
Peptide supplements vs injections: label and record checks
A document-first map for comparing product labels, facility records, FDA records, and certificates. It separates the question each record can answer.
Peptide status guide
What "research use only" means in peptide product labeling
Use the document map to compare seller wording with approval, intended-use, supplier-COA, and human-evidence records.
Peptide document guide
Peptide COA vs Supplement Facts: what each can prove
Use the field-by-field guide to compare a Supplement Facts panel with a supplier COA without treating either document as proof of the other.
Peptide evidence guide
Collagen peptides vs BPC-157: two evidence records
Use the side-by-side guide to keep collagen, BPC-157, formulation, route, population, and regulatory status in separate evidence lanes.
Sources behind this guide
- Strength Conversion in Drug Listing. U.S. Food and Drug Administration. Source date: 2023-04-12.
- Understanding the Risks of Compounded Drugs. U.S. Food and Drug Administration. Source date: 2026-06-22.
- Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. U.S. Food and Drug Administration. Content current as of: 2018-09-20.
- Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling. U.S. Food and Drug Administration. Content current as of: 2005-04-01.
- Is It Really 'FDA Approved'?. U.S. Food and Drug Administration. Source date: 2026-05-04.
- Definition of dose. National Cancer Institute. Accessed: 2026-07-30.
Final volume supplies the concentration denominator
Without a stated final volume, the available quantity remains amount per vial rather than amount per volume.
NutriScore has not commissioned independent clinical review of this article.
Read the editorial process and contributor disclosure and the scoring methodology.
Corrections: support@nutriscore.fit.
Sources: 6 entries, all primary canon, last reviewed 2026-08-26.
For research and educational purposes only. Not medical advice.